Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risk Potential for Organ Dysfunction Associated With Sodium Bicarbonate Therapy (SBT) in Critically Ill Patients

NCT04953013 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT04953013
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04953013 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risk Potential for Organ Dysfunction Associated With Sodium Bicarbonate Therapy (SBT) in Critically Ill Patients
Lead sponsor
Peking University Third Hospital
Phase
Observational
Overall status
Completed
Start date
August 1, 2019
Completion date
September 1, 2020
Enrollment
664 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic acidosis; critically ill patients; organ dysfunction